Future corporate strategy targets large-scale cellular manufacturing needs for upcoming cell and gene therapies RANCHO CORDOVA, Calif., Feb. 17, 2021 — ThermoGenesis Holdings, Inc. (“ThermoGenesis” or the “Company”) (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Company will kick off a … Continued
The Successes and Challenges of CAR T-cell Therapy
ThermoGenesis Holdings Launches a GMP Compliant Automated Cell Washing and Reformulation System -- PXP™-LAVARE -- for CAR-T Manufacturing
ThermoGenesis Provides Regenerative Medicine Solutions
Pioneering the Development of Automated Technologies for Cell-Based Therapeutics and Bioprocessing
For more than two decades ThermoGenesis Holdings, Inc. has developed and commercialized novel cell processing systems and devices providing global researchers, biomanufacturing organizations and clinicians with highly efficient cell processing devices which helped them to deliver better outcomes in various applications in the cell and gene therapy field.
Products for Cellular Processing and Storage
We offer closed automated solutions for manual steps in the cell manufacturing process. Our flexible automated modules provide performance gains in purifying mononuclear cells, washing contaminants from cell fractions, cell selection, and storage while significantly shortening processing times.
3D Bag Set
Cell and gene therapy are relatively new forms of medical treatment, having only been developed about 30 years ago. As such, there is a lot that the general public has yet to understand about these practices. Here, we answer the most commonly asked questions about cell and gene therapies. What is Cell Therapy? Cell … Continued
RANCHO CORDOVA, Calif., Feb. 3, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has completed the development process, submitted a Letter to File and updated the device listing with the U.S. Food and Drug Administration (FDA) … Continued
The four pillars of cancer treatment have always been surgery, chemotherapy, radiation therapy and targeted therapy. Recently, there have been developments leading to what scientists and medical professionals are referring to as the fifth pillar — immunotherapy. Immunotherapy, or therapy that utilizes a patient’s own immune system to help illnesses, has been proven to be … Continued
From injuries that can happen in an instant to normal wear-and-tear from physical activity over time, when there is something wrong with your joints or ligaments, it can cause discomfort and pain that can severely disrupt your way of life. Sometimes, the best way to correct these issues is through surgery, but many physicians will … Continued
RANCHO CORDOVA, Calif., Jan. 7, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Jeff Cauble, Chief Financial Officer, will present a company overview at the H.C. Wainwright BIOCONNECT 2021 Conference. The presentation will be available beginning January … Continued